Biological Sciences

Lewis-Burke has provided campus with a report about the potential implications of the November elections on overall U.S. research and development (R&D) priorities for the next Administration. While there are currently limited details on R&D priorities for a second Trump or a Harris Administration, we assume a future President Harris would have similar priorities as President Biden (with some additional new signature initiatives expected), and we also consider what...

Lewis-Burke Associates periodically provides campus with a Washington Update report. In this report:

The GLIDE program is run by Kimberley Steele, “envisions a future where doctors have a wide variety of therapeutic tools targeting abnormal lymphatic structure and function. Such treatments could prevent and cure primary lymphatic disease and other chronic disorders associated with lymphatic dysfunction, like autoimmune disorders and cancers. GLIDE aims to advance lymphatic medicine, improve our understanding of the role of lymphatic dysfunction in disease, and build effective, affordable, and accessible...

For a full report, view the Lewis-Burke write-up. The National Science Foundation recently announced a new round of the Mid-scale Research Infrastructure-1 program. The Mid-scale RI-1 program supports the design or implementation of unique and compelling research infrastructure projects that respond to an identified need of the research community and/or fulfillment of a national need to enable U.S. researchers to be competitive in a global research environment. Mid-scale...